1933 Industries Adds To Business Development Team With Appointment Of Executive To Advance North American Expansion
1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) (the “Company” or “1933 Industries”) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD products in Nevada, Colorado and California, is pleased to announce the appointment of Mr. Josh Taylor to the Company’s Business Development Division, tasked with identifying and evaluating licensing and acquisition opportunities, establishing distribution networks for the Company’s branded suite of products, and opening new markets for expansion in North America.
Mr. Taylor’ experience as an accomplished sales professional and successful entrepreneur in the legal cannabis space with several years’ experience in business development within the consumer packaged goods and pharmaceutical industries, ideally position him to take on this new role. With sales, marketing and business development roles for Red Bull’s exclusive distributor, Pur Brands, and in the pharmaceutical industry with one of the fastest growing natural food CPG companies, Mr. Taylor brings a wealth of hands on expertise to rapidly advance the Company’s expansion efforts in jurisdictions with cannabis regulations in place. As the co-founder of a cannabis start-up, Mr. Taylor received two High Times Cannabis Cup awards and a Diamond Cup award for solvent-less concentrates. A former NCAA student-athlete and professional golfer, Mr. Taylor is passionate about the cannabis industry and brings a fresh perspective to the organization from a consumer packaged goods perspective.
“We are building and strengthening our organization with seasoned talent to better position us for growth. Josh’s addition to our Business Development division will be invaluable as we progress to the next stage of our development. We are delighted to welcome Josh to the team”, said Mr. Brayden Sutton, President and CEO of the Company.
For business development inquiries, please contact Mr. Taylor at Josh@1933industries.com.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of both Alternative Medicine Association and Infused MFG and 100% of Spire Global Strategy.
Please visit our new website at www.1933industries.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.